Compare WhiteOak Capital Pharma and Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.57
2.02
NAV
₹15.95
₹545.63
Fund Started
16 Jan 2024
04 Jun 1999
Fund Size
₹664.02 Cr
₹4565.95 Cr
Exit Load
-
Exit load of 0.50% if redeemed within 15 days
1 Year
14.48%
10.66%
3 Year
-
25.18%
5 Year
-
15.37%
Equity
99.10%
97.49%
Cash
-7.04%
2.45%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.56% |
JB Chemicals & Pharmaceuticals Ltd. | 6.80% |
Apollo Hospitals Enterprise Ltd. | 4.83% |
Laurus Labs Ltd. | 4.43% |
Fortis Healthcare Ltd. | 3.92% |
Krishna Institute of Medical Sciences Ltd | 3.44% |
Divi's Laboratories Ltd. | 3.29% |
Sai Life Sciences Ltd. | 3.17% |
Max Healthcare Institute Ltd. | 2.83% |
Aurobindo Pharma Ltd. | 2.62% |
Sun Pharmaceutical Industries Ltd. | 11.03% |
Divi's Laboratories Ltd. | 6.57% |
Acutaas Chemicals Ltd. | 6.17% |
Apollo Hospitals Enterprise Ltd. | 5.37% |
Max Healthcare Institute Ltd. | 4.76% |
Aurobindo Pharma Ltd. | 3.90% |
Aster DM Healthcare Ltd. | 3.83% |
Laurus Labs Ltd. | 3.58% |
Biocon Ltd. | 3.52% |
Torrent Pharmaceuticals Ltd. | 3.48% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
16 Jan 2024
04 Jun 1999
